15 Most Promising Stocks Under $100 to Buy
On March 12, Roger Ferguson, former Fed Vice Chair, joined 'Closing Bell' on CNBC to discuss what to expect from the Federal Reserve next week.
Guardant Health Inc. (GH)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 2,800,000 | $285,992,000 | -33% | 5.1% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 2,382,300 | $243,328,122 | +13% | 0.47% |
| 3. | Driehaus Capital Richard Driehaus | 2,143,193 | $218,905,733 | -1% | 1.49% |
| 4. | 104,854,000 | $192,312,721 | -53% | 6.15% | |
| 5. | Point72 Asset Management Steve Cohen | 1,499,169 | $153,125,122 | +1364% | 0.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.82 | 2,187 | $38,962.72 | 12,722 | 2024-03-18 | Filing | |
| $32.78 | 750 | $24,584.25 | 5,193 | 2023-06-09 | Filing | |
| $32.68 | 2,231 | $72,913.77 | 4,443 | 2023-06-09 | Filing | |
| $26.15 | 8,600 | $224,927.84 | 2,049,238 | 2023-03-15 | Filing | |
| $26.33 | 84,452 | $2,223,908.30 | 2,040,638 | 2023-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $88.09 | 348 | $30,655.32 | 8,394 | 2026-03-18 | Filing | |
| $87.04 | 3,000 | $261,111.00 | 43,601 | 2026-03-16 | Filing | |
| $91.30 | 300 | $27,390.03 | 1,193 | 2026-03-06 | Filing | |
| $91.61 | 1,000 | $91,606.50 | 1,493 | 2026-03-06 | Filing | |
| $95.73 | 13,020 | $1,246,349.92 | 37,643 | 2026-03-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,160,768 | $1,242,100,844 | 0.02% | |
| 2. | 11,317,714 | $1,155,991,262 | 0.02% | |
| 3. | 5,315,934 | $542,969,482 | 0.08% | |
| 4. | 4,890,026 | $499,467,256 | 0.42% | |
| 5. | 3,528,656 | $360,416,924 | 0.06% |
News See All
Why Guardant Health’s (GH) 2026 Screening Story Reinforced Piper Sandler’s Bullish View
As of March 13, 2026, Guardant Health carried a Moderate Buy consensus from 23 analysts, based on 21 Buy ratings, one Hold, and one Sell.
11 Best Growth Stocks to Invest in According to Billionaires
Infotech and biotech remain two of the clearer growth pockets because the underlying spending data is still expanding.
Here’s Why Artisan Small Cap Fund Bets on Guardant Health (GH)
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here.
Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition
Guardant Health Inc. (NASDAQ:GH) is one of the best cancer stocks to invest in now. On February 23, Guardant Health Inc.
11 Best Cancer Stocks to Invest In Now
Pharmaceutical companies are a blend of defensive income plays and growth opportunities.
Guardant Health (GH) Gained from Better-Than-Expected Results
Aristotle Funds, an investment advisor, released its “Growth Equity Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S.
Guardant Health, Inc. (NASDAQ:GH) Q4 2025 Earnings Call Transcript
Operator: Thank you for attending the Guardant Health Q4 2025 Earnings Call. My name is Cameron, and I'll be your moderator for today.
What Makes Guardant Health (GH) a Good Healthcare Holding
Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Small Cap Growth Fund”.
13 Best Russell 2000 Stocks to Buy Right Now
On January 6, Royce Investment Partners released their outlook for the small-cap stocks in 2026.
Hedge Fund Resource Center